Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Oct 07, 2024

SELL
$8.72 - $11.56 $104 - $138
-12 Closed
0 $0
Q3 2022

Oct 07, 2024

BUY
$8.48 - $11.13 $101 - $133
12 New
12 $102,000
Q2 2022

Oct 07, 2024

BUY
$9.95 - $12.27 $119 - $147
12 New
12 $126,000
Q1 2022

Oct 07, 2024

BUY
$9.81 - $15.4 $117 - $184
12 New
12 $131,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $9.33B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Fairfield Financial Advisors, LTD Portfolio

Follow Fairfield Financial Advisors, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.